South African Healthcare Market Analysis
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00
South African Healthcare industry is one with a lot of scope, which it has proved in the past and will continue to do so in the future as well. The stupendous and consistent growth rate of the industry can be attributed to the undying government support, which is encouraging the growth of the domestic industry by attracting higher investments. The dedication of the government towards improving the health conditions in the country are also evident from the various provisions made in the recently released budget for the financial year 2011-12.
According to our new research report “South African Healthcare Market Analysis”, South African healthcare industry is expected to sustain its growth pace in near future due to persistent burden of diseases and poor demographic conditions. Besides, the people of the country are affected by the poor health delivery and high costs. Thus, the health authorities are looking towards public-private partnerships to overcome these issues by improving the infrastructure of the healthcare industry. Moreover, the demand and supply of drugs is an important issue, and has a lot of scope for private sector intervention.
South Africans have also become more health conscious, leading to an increase in the usage of more expensive therapies and high innovative products. In this regard, we have done an extensive research and analysis of various segments of the South African healthcare market. The segments covered in the report include: Analysis of Different Disease, Hospitals Services Industry, Pharmaceutical Industry, Medical Devices Industry, and Other emerging market segments.
In addition to the demands regarding hospital services and medical devices, there will be strong demand for primary healthcare level drugs, such as generics, antibiotics, and OTC in coming years as a number of drugs are due to lose their patents. Thus, the pharmaceutical industry is expected to grow at a CAGR of around 15.5% during 2011-2013. Moreover, clinical trials conducted by the private players make South Africa an ideal destination for research. This will draw the attention of world’s leading healthcare providers and make the South African healthcare sector a lucrative area for further investments.
“South African Healthcare Market Analysis” provides thoroughly researched information, authentic data, and comparable statistics of the South African healthcare industry. The report has examined current market trends and industrial developments, to enable clients understand the market structure and its progress in coming years. It presents an insight into the regulatory environment and industry restraints that facilitate devising strategic plans before taking investment decisions to gain optimal returns. The report also contains forecast for all segments of the healthcare industry to present a direction, in which, these segments are likely to move in coming years.
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00
South African Healthcare industry is one with a lot of scope, which it has proved in the past and will continue to do so in the future as well. The stupendous and consistent growth rate of the industry can be attributed to the undying government support, which is encouraging the growth of the domestic industry by attracting higher investments. The dedication of the government towards improving the health conditions in the country are also evident from the various provisions made in the recently released budget for the financial year 2011-12.
According to our new research report “South African Healthcare Market Analysis”, South African healthcare industry is expected to sustain its growth pace in near future due to persistent burden of diseases and poor demographic conditions. Besides, the people of the country are affected by the poor health delivery and high costs. Thus, the health authorities are looking towards public-private partnerships to overcome these issues by improving the infrastructure of the healthcare industry. Moreover, the demand and supply of drugs is an important issue, and has a lot of scope for private sector intervention.
South Africans have also become more health conscious, leading to an increase in the usage of more expensive therapies and high innovative products. In this regard, we have done an extensive research and analysis of various segments of the South African healthcare market. The segments covered in the report include: Analysis of Different Disease, Hospitals Services Industry, Pharmaceutical Industry, Medical Devices Industry, and Other emerging market segments.
In addition to the demands regarding hospital services and medical devices, there will be strong demand for primary healthcare level drugs, such as generics, antibiotics, and OTC in coming years as a number of drugs are due to lose their patents. Thus, the pharmaceutical industry is expected to grow at a CAGR of around 15.5% during 2011-2013. Moreover, clinical trials conducted by the private players make South Africa an ideal destination for research. This will draw the attention of world’s leading healthcare providers and make the South African healthcare sector a lucrative area for further investments.
“South African Healthcare Market Analysis” provides thoroughly researched information, authentic data, and comparable statistics of the South African healthcare industry. The report has examined current market trends and industrial developments, to enable clients understand the market structure and its progress in coming years. It presents an insight into the regulatory environment and industry restraints that facilitate devising strategic plans before taking investment decisions to gain optimal returns. The report also contains forecast for all segments of the healthcare industry to present a direction, in which, these segments are likely to move in coming years.
1. ANALYST VIEW
2. HEALTHCARE MARKET OVERVIEW
3. MARKET ATTRACTIONS
3.1 Favorable Demographics
3.2 Burden of Diseases
3.3 Active Private Sector Participation
3.4 Traditional Medicinal Industry
3.5 Low Penetration
4. ANALYSIS BY DISEASES
4.1 HIV/AIDS
4.2 Tuberculosis
4.3 Malaria
4.4 Cardiovascular and Other Chronic Diseases
4.5 Malnutrition
5. HOSPITAL SERVICES INDUSTRY
5.1 Hospitals and Beds
5.2 Healthcare Human Resources
6. PHARMACEUTICAL MARKET
6.1 Market Overview
6.2 Pharmaceutical Imports and Exports
6.3 Prescription and OTC Drugs
6.4 Generics
7. MEDICAL DEVICES MARKET
8. EMERGING MARKET SEGMENTS
8.1 Health Insurance
8.2 Medical Tourism
8.3 Clinical Trials
9. GOVERNMENT INITIATIVES AND REGULATORY ENVIRONMENT
9.1 Hospital Services Market
9.2 Pharmaceutical Market
9.3 Medical Devices Market
10. INDUSTRY RESTRAINTS
10.1 Poor Retention Rate of Healthcare Professionals
10.2 Regulations on Medicines Prices
2. HEALTHCARE MARKET OVERVIEW
3. MARKET ATTRACTIONS
3.1 Favorable Demographics
3.2 Burden of Diseases
3.3 Active Private Sector Participation
3.4 Traditional Medicinal Industry
3.5 Low Penetration
4. ANALYSIS BY DISEASES
4.1 HIV/AIDS
4.2 Tuberculosis
4.3 Malaria
4.4 Cardiovascular and Other Chronic Diseases
4.5 Malnutrition
5. HOSPITAL SERVICES INDUSTRY
5.1 Hospitals and Beds
5.2 Healthcare Human Resources
6. PHARMACEUTICAL MARKET
6.1 Market Overview
6.2 Pharmaceutical Imports and Exports
6.3 Prescription and OTC Drugs
6.4 Generics
7. MEDICAL DEVICES MARKET
8. EMERGING MARKET SEGMENTS
8.1 Health Insurance
8.2 Medical Tourism
8.3 Clinical Trials
9. GOVERNMENT INITIATIVES AND REGULATORY ENVIRONMENT
9.1 Hospital Services Market
9.2 Pharmaceutical Market
9.3 Medical Devices Market
10. INDUSTRY RESTRAINTS
10.1 Poor Retention Rate of Healthcare Professionals
10.2 Regulations on Medicines Prices
LIST OF FIGURES:
Figure 2-1: Healthcare Expenditure (% of GDP), 2007-2009
Figure 2-2: Share of Public, Private and NGO in Healthcare Expenditure (2009-10)
Figure 2-3: Share of Healthcare Expenditure in Government Expenditure (2007-08 to 2010-11)
Figure 3-1: Infant Mortality Rate under Age Group 5 years (per 1000 live births), 2008-2010
Figure 4-1: HIV Prevalence in Sub-Saharan Africa (%), 2009
Figure 4-2: Number of Malaria Cases (2008-2010)
Figure 5-1: Number of Public Sector Hospital Beds (2007-2009)
Figure 5-2: Number of Private Sector Hospital Beds (2007-2009)
Figure 5-3: Additional Demand for Number of Hospital Beds (2011-2013)
Figure 5-4: Number of Registered Doctors (2008-2010)
Figure 5-5: Additional Demand for Number of Doctors (2011-2013)
Figure 6-1: Pharmaceutical Market (Billion US$), 2008-2010
Figure 6-2: Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 6-3: Pharmaceutical Imports (Billion US$), 2008-2010
Figure 6-4: Pharmaceutical Exports (Million US$), 2008-2010
Figure 6-5: Share of Prescription and OTC Drugs (2010)
Figure 6-6: Share of Generics and Patented in Pharmaceutical Market (2010)
Figure 6-7: Share of Key Players in Generics Market (2010)
Figure 7-1: Medical Devices Market (Billion US$), 2008-2010
Figure 7-2: Medical Devices Market by Product (%), 2010
Figure 7-3: Forecast for Medical Devices Market (Billion US$), 2011-2013
Figure 7-4: Forecast for Medical Devices Market by Product (%), 2013
Figure 8-1: Number of Medical Tourists (‘000), 2008-2010
Figure 8-2: Forecast for Number of Medical Tourists (‘000), 2011-2013
Figure 9-1: Forecast for Share of State Conditional Grants (2011-12)
Figure 9-2: Market Entry Path for Pharmaceutical Companies
Figure 10-1: Vacancies in the Public Health Sector (%), 2008-2010
Figure 2-1: Healthcare Expenditure (% of GDP), 2007-2009
Figure 2-2: Share of Public, Private and NGO in Healthcare Expenditure (2009-10)
Figure 2-3: Share of Healthcare Expenditure in Government Expenditure (2007-08 to 2010-11)
Figure 3-1: Infant Mortality Rate under Age Group 5 years (per 1000 live births), 2008-2010
Figure 4-1: HIV Prevalence in Sub-Saharan Africa (%), 2009
Figure 4-2: Number of Malaria Cases (2008-2010)
Figure 5-1: Number of Public Sector Hospital Beds (2007-2009)
Figure 5-2: Number of Private Sector Hospital Beds (2007-2009)
Figure 5-3: Additional Demand for Number of Hospital Beds (2011-2013)
Figure 5-4: Number of Registered Doctors (2008-2010)
Figure 5-5: Additional Demand for Number of Doctors (2011-2013)
Figure 6-1: Pharmaceutical Market (Billion US$), 2008-2010
Figure 6-2: Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 6-3: Pharmaceutical Imports (Billion US$), 2008-2010
Figure 6-4: Pharmaceutical Exports (Million US$), 2008-2010
Figure 6-5: Share of Prescription and OTC Drugs (2010)
Figure 6-6: Share of Generics and Patented in Pharmaceutical Market (2010)
Figure 6-7: Share of Key Players in Generics Market (2010)
Figure 7-1: Medical Devices Market (Billion US$), 2008-2010
Figure 7-2: Medical Devices Market by Product (%), 2010
Figure 7-3: Forecast for Medical Devices Market (Billion US$), 2011-2013
Figure 7-4: Forecast for Medical Devices Market by Product (%), 2013
Figure 8-1: Number of Medical Tourists (‘000), 2008-2010
Figure 8-2: Forecast for Number of Medical Tourists (‘000), 2011-2013
Figure 9-1: Forecast for Share of State Conditional Grants (2011-12)
Figure 9-2: Market Entry Path for Pharmaceutical Companies
Figure 10-1: Vacancies in the Public Health Sector (%), 2008-2010
LIST OF TABLES:
Table 3-1: Demographic Characteristics (2008-2010)
Table 4-1: HIV Prevalence (%), 2007-2010
Table 4-2: Demographic Scenario of Anti-Retroviral Therapy (ART) Drugs (2007-2009)
Table 4-3: TB Statistics (‘000), 2009
Table 4-4: Diabetes Statistics (Age Group 20-79), 2010
Table 5-1: Number of Public Sector Health Facilities by Type (2009)
Table 5-2: Number of Registered Health Professionals
Table 5-3: Available Nursing Manpower (2010)
Table 8-1: Population Covered under Medical Schemes (%), 2007-2009
Table 3-1: Demographic Characteristics (2008-2010)
Table 4-1: HIV Prevalence (%), 2007-2010
Table 4-2: Demographic Scenario of Anti-Retroviral Therapy (ART) Drugs (2007-2009)
Table 4-3: TB Statistics (‘000), 2009
Table 4-4: Diabetes Statistics (Age Group 20-79), 2010
Table 5-1: Number of Public Sector Health Facilities by Type (2009)
Table 5-2: Number of Registered Health Professionals
Table 5-3: Available Nursing Manpower (2010)
Table 8-1: Population Covered under Medical Schemes (%), 2007-2009
